The MAPKAPK2 protein levels were significantly elevated in glioma tissues compared with the para-tumor tissues and were obviously higher in GBM compared with low-grade glioma (Figures 2B–D, Table 2). The gene discussed is MAPKAPK2; the disease is central nervous system cancer.